ARTIDENTAL 40 mg/0,005 mg/ml România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

artidental 40 mg/0,005 mg/ml

laboratorios inibsa, s.a. - spania - combinatii (articainum+adrenalinum) - sol. inj. - 40mg/0,005mg/ml - anestezice locale amide

CISPLATINA ACCORD 1 mg/ml România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

cisplatina accord 1 mg/ml

accord healthcare limited - marea britanie - cisplatinum - conc. pt. sol. perf. - 1mg/ml - alte antineoplazice compusi ai platinei

CLORHIDRAT DE DOPAMINA ZENTIVA 5 mg/ml România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

clorhidrat de dopamina zentiva 5 mg/ml

zentiva s.a. - romania - dopaminum - conc. pt. sol. perf. - 5mg/ml - stimulante cardiace excl. glicozizi cardiotonici med.adrenergice si dopaminergice

Oxytocin-Richter 5 UI/ml soluţie injectabilă Republica Moldova - română - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

oxytocin-richter 5 ui/ml soluţie injectabilă

gedeon richter plc - oxytocinum - soluţie injectabilă - 5 ui/ml

Yescarta Uniunea Europeană - română - EMA (European Medicines Agency)

yescarta

kite pharma eu b.v. - axicabtagene ciloleucel - lymphoma, follicular; lymphoma, large b-cell, diffuse - agenți antineoplazici - yescarta is indicated for the treatment of adult patients with diffuse large b cell lymphoma (dlbcl) and high-grade b-cell lymphoma (hgbl) that relapses within 12 months from completion of, or is refractory to, first-line chemoimmunotherapy. yescarta is indicated for the treatment of adult patients with relapsed or refractory (r/r) dlbcl and primary mediastinal large b cell lymphoma (pmbcl), after two or more lines of systemic therapy. yescarta is indicated for the treatment of adult patients with r/r follicular lymphoma (fl) after three or more lines of systemic therapy.

LIDOCAINA KABI 10 mg/ml România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

lidocaina kabi 10 mg/ml

labesfal - laboratÓrios almiro s.a.(fresenius kabi - portugalia - lidocainum - sol. inj. - 10mg/ml - anestezice locale amide

LIDOCAINA KABI 20 mg/ml România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

lidocaina kabi 20 mg/ml

labesfal - laboratÓrios almiro s.a.(fresenius kabi - portugalia - lidocainum - sol. inj. - 20mg/ml - anestezice locale amide

Tecartus Uniunea Europeană - română - EMA (European Medicines Agency)

tecartus

kite pharma eu b.v. - autologous peripheral blood t cells cd4 and cd8 selected and cd3 and cd28 activated transduced with retroviral vector expressing anti-cd19 cd28/cd3-zeta chimeric antigen receptor and cultured (brexucabtagene autoleucel) - limfom, mantle-cell - agenți antineoplazici - mantle cell lymphomatecartus is indicated for the treatment of adult patients with relapsed or refractory mantle cell lymphoma (mcl) after two or more lines of systemic therapy including a bruton’s tyrosine kinase (btk) inhibitor. acute lymphoblastic leukaemiatecartus is indicated for the treatment of adult patients 26 years of age and above with relapsed or refractory b-cell precursor acute lymphoblastic leukaemia (all).

BUPIVACAINA ROMPHARM 5 mg/ml România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

bupivacaina rompharm 5 mg/ml

rompharm company s.r.l. - romania - bupivacainum - sol. inj. - 5mg/ml - anestezice locale amide

MYKRONOR 10 micrograme/ml România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

mykronor 10 micrograme/ml

laboratoire aguettant - franta - noradrenalinum - sol. inj./perf. - 10micrograme/ml - stimulante cardiace excl. glicozizi cardiotonici med.adrenergice si dopaminergice